Ledger.Open graph →
SEC Form D · Amendment · filed December 16, 2020

Dianthus Therapeutics, Inc

Offering
$7.0M
Sold
$6.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Jenne Britell · Austin, TXExec · DirectorMatthew Topliff · Malvern, PADirectorJason Keiser · Malvern, PAExec · DirectorJonathan E. Violin · Waltham, MAExec · DirectorRoss Buhrdorf · Austin, TXDirectorLeon O. Moulder, Jr · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗